Is it possible to develop drugs that act more selectively on large arteries?

BACKGROUND Patients with high pulse pressures have an increased risk for cardiovascular events. Drugs that selectively decrease high pulse pressure may be of interest for these patients. Such drugs have a more pronounced effect on large arteries than on resistance vessels. OBJECTIVE To compare the selectivity to large arteries of the new nitric oxide donor sinitrodil with the classic nitrate isosorbide dinitrate in healthy young men in order to investigate whether it is possible to develop drugs that act more selectively on large arteries. DESIGN The study had a double-blind, 5-way cross-over design. In randomized order, subjects received a single oral dose of 10 mg sinitrodil, 20 mg sinitrodil, 40 mg sinitrodil, isosorbide dinitrate and placebo. Measurements were performed before and 45 min after administration of the drugs. Between each drug administration, at least 3 days of wash-out was allowed. METHODS The effects of the drugs on large arteries and resistance vessels were assessed by their effects on brachial artery compliance and total peripheral resistance, respectively. RESULTS Brachial artery compliance increased gradually with increasing doses of sinitrodil (by 10, 20 and 27% with 10, 20 and 40 mg sinitrodil, respectively). Total peripheral resistance index decreased with isosorbide dinitrate (by 11%) and 40 mg sinitrodil (by 7%), while it remained unchanged with 10 mg and 20 mg sinitrodil. CONCLUSIONS The results of this study show that it may be possible to develop drugs with a higher selectivity for large arteries. Such drugs may be good candidates to decrease high pulse pressure without substantially decreasing mean and diastolic blood pressures.

[1]  L A Moyé,et al.  Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. , 1997, Circulation.

[2]  L Guize,et al.  Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. , 1997, Hypertension.

[3]  L. Kuller,et al.  The importance of pulsatile components of hypertension in predicting carotid stenosis in older adults , 1997, Journal of hypertension.

[4]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[5]  H. S. Struijker Boudier,et al.  Effects of antihypertensive agents on local arterial distensibility and compliance. , 1995, Hypertension.

[6]  Jing Fang,et al.  Measures of blood pressure and myocardial infarction in treated hypertensive patients , 1995, Journal of hypertension.

[7]  F. Tursi,et al.  Mechanism of ITF 296‐Induced Vasorelaxation Compared to Nitroglycerin and Isosorbide Dinitrate: Relationship Between Relaxation of Rabbit Aorta and Tissue cGMP , 1995, Journal of cardiovascular pharmacology.

[8]  W. L. Ooi,et al.  Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. , 1994, Hypertension.

[9]  G. London,et al.  Wave reflections. Clinical and therapeutic aspects , 1993 .

[10]  M. Safar,et al.  Mechanism of Nitrate‐Induced Improvement on Arterial Compliance Depends on Vascular Territory , 1992, Journal of cardiovascular pharmacology.

[11]  M. O'Rourke,et al.  Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. , 1990, Hypertension.

[12]  A P Avolio,et al.  Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. , 1990, European heart journal.

[13]  R S Reneman,et al.  Assessment of the distensibility of superficial arteries. , 1990, Ultrasound in medicine & biology.

[14]  L Guize,et al.  Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. , 1989, Hypertension.

[15]  L H Kuller,et al.  Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. , 1989, Stroke.

[16]  L. Kuller,et al.  Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. , 1988, Circulation.

[17]  L. Kuller,et al.  Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program pilot project. , 1987, American journal of epidemiology.

[18]  M. Safar,et al.  Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. , 1987, The American journal of cardiology.

[19]  M. Packer,et al.  Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study. , 1985, American heart journal.

[20]  E. Bolson,et al.  The Mechanisms of Nitroglycerin Action: Stenosis Vasodilatation as a Major Component of the Drug Response , 1981, Circulation.

[21]  D L McGee,et al.  Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. , 1981, JAMA.

[22]  W. Kannel,et al.  Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. , 1971, The American journal of cardiology.